Transition report pursuant to Rule 13a-10 or 15d-10

Consolidated Statements of Cash Flows

v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 11 Months Ended 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Jan. 31, 2013
Jan. 31, 2012
Operating activities        
Net loss $ (27,017) $ (24,462) $ (38,148) $ (16,107)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities        
Depreciation and amortization 10,112 6,406 7,076 4,455
Loss on disposition of assets   23 23 296
Stock-based compensation 40,041 23,283 25,500 9,187
Remeasurement of preferred stock warrants       4,499
Amortization of premium on investments 237 329 360 246
Amortization of debt issuance costs 220 242 264 190
Changes in assets and liabilities        
Accounts receivable (60,613) (43,487) (36,672) (24,526)
Prepaid expenses and other assets (7,891) (2,189) (3,752) 156
Accounts payable and accrued liabilities 17,352 10,419 4,963 (865)
Accrued royalties 13,027 17,525 19,261 15,742
Accrued compensation (3,393) 2,085 9,598 8,147
Deferred revenue 13,384 10,285 10,034 3,322
Reimbursement of cost of leasehold improvements 1,555 1,243 1,243 616
Net cash provided by (used in) operating activities (2,986) 1,702 (250) 5,358
Investing activities        
Purchases of property and equipment (21,180) (11,809) (7,580) (11,644)
Purchases of patents (8,000)      
Purchases of investments (224,549) (59,559) (65,168) (66,890)
Proceeds from maturities of short-term investments 42,210 79,603 87,933 19,984
Payments related to acquisition (400)      
Net cash provided by (used in) investing activities (211,919) 8,235 15,185 (58,550)
Financing activities        
Borrowings under debt arrangements 10,000      
Repayments of debt (10,000)     (7,596)
Proceeds from follow-on offering, net of issuance costs 378,654      
Proceeds from issuance of common stock 16,793 5,877 6,669 2,074
Proceeds from exercise of preferred stock warrants       165
Proceeds from initial public offering, net       90,632
Payment of dividends to preferred stockholders at initial public offering       (31,005)
Payment of debt issuance costs in connection with the debt refinancing (450)      
Net cash provided by financing activities 394,997 5,877 6,669 54,270
Effects of foreign currency translation (62) (1) (5)  
Net increase in cash and cash equivalents 180,030 15,813 21,599 1,078
Cash and cash equivalents at beginning of period 65,725 44,126 44,126 43,048
Cash and cash equivalents at end of period 245,755 59,939 65,725 44,126
Supplemental disclosures of noncash financing activities        
Conversion of preferred stock warrants into common stock warrants       (2,151)
Conversion of preferred stock into common stock       (124,341)
Accruals of preferred stock dividends, net       25,218
Accretion of preferred stock issuance cost       110
Supplemental disclosures of cash flow information        
Cash paid during the period for income taxes 26     125
Cash paid during the period for interest 18 283 289 887
Purchases of property and equipment recorded in accounts payable and accrued liabilities $ 7,910 $ 726 $ 1,952